SeraCare Expands R&D In Milford
Life sciences manufacturer SeraCare Life Sciences of Milford said it has expanded its research and development facilities at its headquarters, driven by new manufacturing opportunities it’s undertaking with partners, the company said.
The addition of about 5,000 square feet of R&D space also enhances the company's ability to make innovative molecular diagnostic kits and components for physicians under stringent design control and quality systems. The facility will include an ISO 8-classified clean room, four advanced molecular laboratories and a sophisticated air handling and purifying system.
"The expansion of our research and manufacturing capabilities is an important element in our overall growth strategy for SeraCare," said SeraCare CEO Charlie Mamrak. "Over the past year, we have made a number of significant investments including the recent acquisition of (Kirkegaard & Perry Laboratories) KPL, a leader in immunoassay reagents, and implementation of SAP enterprise resource planning software. These investments position SeraCare for continued growth in both our existing customer base as well as emerging markets such as molecular and companion diagnostics."
Last month, SeraCare acquired KPL, of Gaithersburg, Md., a provider of antibodies and related materials for the diagnostic and life sciences markets. The price of the deal was not disclosed.
WBJ Web Partners
Most Recent
Most Recent
0 Comments